# | Name | Compound Key | Action Type | Relation | Activity Value | Units | Assay ID | Assay Description | Comment | Assay | Assay Organism | |
---|---|---|---|---|---|---|---|---|---|---|---|---|
1. | ALA4473101 | 17f | MIC | > | 32 | ug ml-1 | ALA5231941 | ug.mL-1 | Cryptococcus neoformans | |||
2. | ALA4473101 | 17f | MIC | > | 32 | ug ml-1 | ALA5231940 | ug.mL-1 | Candida albicans | |||
3. | ALA4473101 | 17f | MIC | > | 32 | ug ml-1 | ALA5231939 | ug.mL-1 | Pseudomonas aeruginosa | |||
4. | ALA4473101 | 17f | MIC | > | 32 | ug ml-1 | ALA5231938 | ug.mL-1 | Acinetobacter baumannii | |||
5. | ALA4473101 | 17f | MIC | > | 32 | ug ml-1 | ALA5231937 | ug.mL-1 | Klebsiella pneumoniae | |||
6. | ALA4473101 | 17f | MIC | > | 32 | ug ml-1 | ALA5231936 | ug.mL-1 | Escherichia coli | |||
7. | ALA4473101 | 17f | MIC | > | 32 | ug ml-1 | ALA5231935 | ug.mL-1 | Staphylococcus aureus | |||
8. | ALA4473101 | 17f | IC50 | > | 50 | uM | ALA5231934 | nM | Entamoeba histolytica | |||
9. | ALA4473101 | 17f | IC50 | = | 1.7 | uM | ALA5231933 | 5.77 | nM | Giardia intestinalis | ||
10. | ALA4473101 | 17f | Activity | = | 38 | % | ALA5231924 | % | Trypanosoma brucei brucei | |||
11. | ALA4473101 | 17f | CC50 | > | 100 | uM | ALA5231921 | nM | Homo sapiens | |||
12. | ALA4473101 | 17f | IC50 | = | 2.9 | uM | ALA5231920 | 5.54 | nM | Trypanosoma cruzi | ||
13. | ALA4473101 | 17f | MIC90 | = | 0.5 | ug ml-1 | ALA5231918 | ug.mL-1 | Mycobacterium tuberculosis | |||
14. | ALA4473101 | 17f | MIC90 | = | 0.125 | ug ml-1 | ALA5231917 | ug.mL-1 | Mycobacterium tuberculosis | |||
15. | ALA4473101 | 17f | solubility | < | 1 | uM | ALA5231916 | nM | ||||
16. | ALA4473101 | 17f | solubility | = | 1.2 | uM | ALA5231915 | nM | ||||
17. | ALA4473101 | 17f | GI | = | 38 | % | ALA4384261 | % | Trypanosoma brucei brucei | |||
18. | ALA4473101 | 17f | Ratio | = | 1 | ALA4384258 | ||||||
19. | ALA4473101 | 17f | Drug recovery | = | 99 | % | ALA4384257 | % | ||||
20. | ALA4473101 | 17f | Drug recovery | = | 88 | % | ALA4384256 | % |